Literature DB >> 15251564

Pseudohypercalcemia in an elderly patient with multiple myeloma: report of a case and review of literature.

J D Schwab1, M A Strack, L D Hughes, J L Shaker.   

Abstract

Hypercalcemia, a common complication of multiple myeloma, is primarily caused by increased bone resorption. The increase in total calcium is usually associated with an increase in the ionized calcium (Ca(I)), and the hypercalcemia is frequently symptomatic. Rarely, pseudohypercalcemia in multiple myeloma is caused by binding of calcium to the abnormal immunoglobulin. In this setting, the Ca(I) is normal. We describe a 90-year-old woman with an IgA-k myeloma who had substantial increases in the total calcium but normal levels of Ca(I). Clinicians should recognize this unusual phenomenon to avoid unnecessary and potentially toxic therapy.

Entities:  

Year:  1995        PMID: 15251564     DOI: 10.4158/EP.1.6.390

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  2 in total

1.  Transient Hypophosphatemia: A Dangerous Event in Multiple Myeloma.

Authors:  Paula Jeffs; Michelle Mangual-García; Alex González-Bóssolo; Nadyeschka Rivera-Santana
Journal:  Case Rep Endocrinol       Date:  2021-01-16

2.  Pseudohypercalcemia in Multiple Myeloma: A Case Report.

Authors:  Farzaneh Ashrafi; Bijan Iraj; Pardis Nematollahi; Ali Darakhshandeh
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.